Skip to main content

Tweets

Rheumatologists: What do you devote your weekends to?

Dr. John Cush @RheumNow ( View Tweet )

3 years 5 months ago
2022 ACR Classification Criteria for GCA: (must be >50yrs) 6+ points needed for #GCA AM stiff should/neck +2 Visual loss +3 Jaw Claud +2 Temp HA +2 Scalp tender +2 Hi ESR/CRP +3 +Bx or US +5 axillary +2 +PEG Aorta +2 https://t.co/ZtVlYhpwru https://t.co/L1sv3L9p37
Dr. John Cush @RheumNow ( View Tweet )
3 years 5 months ago
Register for RheumNow Live today and qualify for early bird pricing. Among our 24 speakers, Drs. Coates, Ruderman, and Champers will lead a session on the Modern Management of Psoriatic Arthritis. https://t.co/tiJssRdzAw https://t.co/Rar27hRahf
Dr. John Cush @RheumNow ( View Tweet )
3 years 5 months ago
Population data on incidence of #RA from Northern Savo, Finland, 46 new RA cases in 2020; incidence seropos RA was 22.3 per 100K. Incidence did not differ by gender but decreased w/ age < 55 years, p = 0.003 (change in risk factors?) https://t.co/QxMwKh7wIU
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago

Ferritin may be more than biomarker in Stills, etc - may contribute directly to pathogenesis. Ferritin causes PMN activation & neutrophil extracellular traps (NETs). Could this be targeted therapeutically? https://t.co/42KeTbVsQb https://t.co/imLipzmf4R

Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
ACP Guidelines on Fracture Prevention in at-risk Adults The American College of Physicians (ACP) has updated its 2017 recommendations on pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults. https://t.co/FE6WEs1Oug https://t.co/Mvgx8sVLPh
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
Hosp study of 2809 admissions, found 1+adverse events (AE) in 24%. Among 978 AE, 23% (222) were preventable; 32% (316) serious. Preventable AE occurred in 1/15 admissions (serious 1/100). Drug AE were most common (39%) https://t.co/gqty53ccyH https://t.co/GxDBoEhxeM
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
JAK Inhibitor Promising for Polymyalgia Rheumatica Tofacitinib appeared highly effective against PMR in a small single-arm trial, researchers said, suggesting another potential alternative to long-term corticosteroids. https://t.co/XNhICcDU7t https://t.co/WWHNRP3aeP
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
"It takes alot of courage to reach out and say 'I need some help on this one'" (Carla Harris) Put on your big-boy pants, woman-up and ask for advice, not from anyone - go to the right person/people - you know who they are! https://t.co/GUs1nCvXeU
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
Holes in TH17 cells release IL-1α on NLRP3 activation Certain T cells can secrete cytokines that are normally part of the innate immune system, as researchers from the Leibniz-HKI and an international research team discovered. https://t.co/lLHD66D3RP https://t.co/cym7SGD2WX
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
Free great handout on DRESS - Drug Reaction With Eosinophilia and Systemic Symptoms. May affect adults or children; usually 2 to 8 weeks after beginning a medication. ~1 in 1000 taking specific drugs get DRESS. Allopurinol is a common cause https://t.co/X8lHtGVunC https://t.co/OjCzUXWJcz
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
anti-mitochondrial antibodies (AMA) in were assayed in 404 #RA patients & found to positive in 14-26%. Importantly AMA Abs were associated with erosive disease (p<0.05) and interstitial lung disease (p<0.01), independent of CCP or RF https://t.co/ZcrOYr0cWX https://t.co/KvZ3N5IiCB
Dr. John Cush @RheumNow ( View Tweet )
3 years 6 months ago
×